| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/22/2011 | US7893326 Plants and seeds of hybrid corn variety CH080290 |
| 02/22/2011 | US7893322 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants |
| 02/22/2011 | US7893315 Derivation of embryonic stem cells and embryo-derived cells |
| 02/22/2011 | US7893246 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 02/22/2011 | US7893245 Interfering RNA molecules |
| 02/22/2011 | US7893235 Nucleotide sequences coding orphan receptor for use in identifying modulators for prevention and treatment of diabetes |
| 02/22/2011 | US7893234 EPSP synthase highly tolerant of glyphosate |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7893216 Anti-human trail receptor DR5 monoclonal antibody (AD5-10), method thereof and use of the same |
| 02/22/2011 | US7893211 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 02/22/2011 | US7893209 Slo2, novel potassium channel proteins from human brain |
| 02/22/2011 | US7893205 Hemopoietin receptor protein, NR12 |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893054 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7893033 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 02/22/2011 | US7893032 NgR variants and compositions thereof for suppressing axonal growth inhibition |
| 02/22/2011 | US7892835 Pluripotent stem cell growing method |
| 02/22/2011 | US7892831 Method for in vitro mass culture of Aloe vera |
| 02/22/2011 | US7892830 Clonal culture of human pluripotent stem cells |
| 02/22/2011 | US7892829 Cardiac muscle regeneration using mesenchymal stem cells |
| 02/22/2011 | US7892828 Method of identifying a MHC class I restricted T cell response |
| 02/22/2011 | US7892827 Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4) |
| 02/22/2011 | US7892826 Human cell clones having an endogeneous urotensin II receptor |
| 02/22/2011 | US7892822 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 02/22/2011 | US7892812 Chrysosporium cellulase and methods of use |
| 02/22/2011 | US7892803 Gene and uses therefor to modify pasture qualities of crops |
| 02/22/2011 | US7892799 Method for in vivo, ex vivo and in vitro repair and regeneration of cartilage |
| 02/22/2011 | US7892793 Allele-specific RNA interference |
| 02/22/2011 | US7892790 Protein expression in rodent cells |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | US7892770 Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods |
| 02/22/2011 | US7892736 Selecting a domestic animal for having desired genotypic properties bytesting the animal for the presence of a parentally imprinted quantitative trait locus; particularly selecting properties related to muscle mass, fat deposition, sow prolificacy, and/or sow longevity in pigs |
| 02/22/2011 | US7892725 Process for storing a sperm dispersion |
| 02/22/2011 | US7892578 Treatment of hematologic disorders |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/22/2011 | US7892535 Preventing transfusion related complications in a recipient of a blood transfusion |
| 02/22/2011 | US7892534 Differentiating human trophoblast stem cells in mammalian straitum |
| 02/22/2011 | US7892532 Intracellular delivery of osteoinductive proteins and peptides |
| 02/22/2011 | CA2563841C Use of porous membrane to support developing conifer somatic embryos |
| 02/22/2011 | CA2554195C Peptide originating in epidermal growth factor receptor (egfr) |
| 02/22/2011 | CA2470564C Recombinant polypeptides |
| 02/22/2011 | CA2441566C Blood cell production via activation of the hemoglobin scavenger receptor |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/22/2011 | CA2431230C A device and method for seed-train expansion of mammalian cells |
| 02/22/2011 | CA2423833C Viruses targeted to hypoxic cells and tissues |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2356255C Use of a xylanase in the preparation of dough |
| 02/22/2011 | CA2350882C Transfection reagents |
| 02/22/2011 | CA2310806C Pectin degrading enzymes from bacillus licheniformis |
| 02/22/2011 | CA2143491C A novel peptide related to human programmed cell death and dna encoding it |
| 02/17/2011 | WO2011020120A2 Multi-transgenic pigs for diabetes treatment |
| 02/17/2011 | WO2011020079A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | WO2011019957A1 Method for formation of induced pluripotent stem cells |
| 02/17/2011 | WO2011019953A1 Defined conditions for human embryonic stem cell culture and passage |
| 02/17/2011 | WO2011019822A2 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products |
| 02/17/2011 | WO2011019630A2 Treatment of astrocytes-tumor cells with inhibitors of endothelin receptors |
| 02/17/2011 | WO2011019619A1 Production of proteins in glutamine-free cell culture media |
| 02/17/2011 | WO2011019401A2 Cell coated implantable device |
| 02/17/2011 | WO2011019366A2 Growth factor extractor |
| 02/17/2011 | WO2011019124A1 Agmatine as an agent for enhancing stem cell efficacy |
| 02/17/2011 | WO2011019092A1 Method for inducing differentiation of pluripotent stem cells into neural precursor cells |
| 02/17/2011 | WO2011019081A1 Light-receiving channel rhodopsin having improved expression efficiency |
| 02/17/2011 | WO2011018485A1 Medium for preserving organs, biological tissue, or living cells |
| 02/17/2011 | WO2010111711A3 Ganglioside biosynthesis modulators |
| 02/17/2011 | WO2010056755A4 Microfluidic embryo and gamete culture systems |
| 02/17/2011 | US20110041222 Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants |
| 02/17/2011 | US20110041221 Engineering enzymatically susceptible phytases |
| 02/17/2011 | US20110041220 Mutant gene that regulates oil-and-fat content in seed and method for regulating oil-and-fat content in seed |
| 02/17/2011 | US20110041219 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/17/2011 | US20110041218 Method for producing sclareol |
| 02/17/2011 | US20110041217 Onions With High Storage Ability, High Soluble Solids Content And/Or Low Pungency |
| 02/17/2011 | US20110041216 Nitrate reductases from red algae, compositions and methods of use thereof |
| 02/17/2011 | US20110041215 Lipid Metabolism Protein And Uses Thereof I (BZIP Transcription Factor) |
| 02/17/2011 | US20110041213 Novel bacillus thuringiensis insecticidal proteins |
| 02/17/2011 | US20110041212 Storage-induced promoter |
| 02/17/2011 | US20110041210 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 02/17/2011 | US20110041208 Promoter, promoter control elements, and combinations, and uses thereof |
| 02/17/2011 | US20110041205 Tomato hybrid hnx12860544 |
| 02/17/2011 | US20110041197 Promoter-Regulated Differentiation-Dependent Self-Deleting Cassette |
| 02/17/2011 | US20110041196 miRNA-Regulated Differentiation-Dependent Self-Deleting Cassette |
| 02/17/2011 | US20110041192 Recombinant non-human mammalian model for hepatitis infection and immunopathogenesis |
| 02/17/2011 | US20110041191 Animal model, and products and methods useful for the production thereof |
| 02/17/2011 | US20110040259 Method for allogeneic cell therapy |
| 02/17/2011 | US20110040074 Production methods |
| 02/17/2011 | US20110039916 Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof |
| 02/17/2011 | US20110039915 IMMUNOSTIMULATORY siRNA MOLECULES |
| 02/17/2011 | US20110039914 Modified rnai polynucleotides and uses thereof |
| 02/17/2011 | US20110039913 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression |
| 02/17/2011 | US20110039910 Modulation of apolipoprotein (a) expression |
| 02/17/2011 | US20110039870 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 02/17/2011 | US20110039824 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors |
| 02/17/2011 | US20110039820 Lactam compounds useful as protein kinase inhibitors |
| 02/17/2011 | US20110039792 Selective Targeting Agents for Mitochondria |
| 02/17/2011 | US20110039791 Acetylcholinesterase (ache)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof |
| 02/17/2011 | US20110039788 Compositions, methods and kits for detecting and treating cancer |
| 02/17/2011 | US20110039780 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof |
| 02/17/2011 | US20110039777 Cancer treatment using natriuretic peptides |
| 02/17/2011 | US20110039775 Thyroid stimulating hormone fusion proteins |
| 02/17/2011 | US20110039765 Bioactive Molecules Produced by Probiotic Bacteria |